<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1210211146
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2021
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Lindacil
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CLINDAMYCIN HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        150
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Capsule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        16
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        17.10
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Alrai Pharmaceutical industry Co. (L.L.C)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Alrai Pharmaceutical industry Co. (L.L.C)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 540]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ZIMMO TRADING ESTABLISHMENT
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Alrai Pharmaceutical industry Co. (L.L.C)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        D10AF01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>LINDACIL capsules contains the active substance Clindamycin hydrochloride which belongs to an antibiotic group called Lincosamide used in the treatment of serious bacterial infections.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take LINDACIL </strong></p><p>If you are allergic (hypersensitive) to Clindamycin, lincomycin or to any of the other ingredients in this medicine (listed in section 6).</p><p><strong>Warnings and precautions </strong></p><p><strong>Talk to your doctor or pharmacist before using LINDACIL if: </strong></p><p>&bull; You have diarrhea or usually get diarrhea when you take antibiotics or have ever suffered from problems with your stomach or intestines. If you develop severe or prolonged or bloody diarrhea during or after using LINDACIL <strong>tell your doctor immediately </strong>since it may be necessary to interrupt the treatment. This may be a sign of bowel inflammation (pseudomembranous colitis) which can occur following treatment with antibiotics.</p><p>&bull; You suffer from problems with your kidneys or liver.</p><p>&bull; You suffer from asthma, eczema or hay fever.</p><p>&bull; You develop any severe skin reactions or hypersensitivity to LINDACIL.</p><p><strong>Other medicines and LINDACIL </strong></p><p>Tell your doctor or pharmacist or nurse if you are taking, have recently taken or might take any other medicines including those obtained without a prescription:</p><p>&bull; Muscle relaxants used for operations (neuromuscular blockers).</p><p>&bull; Oral contraceptive pills. You should use extra contraception such as condoms whilst taking LINDACIL and for seven days after taking LINDACIL.</p><p>&bull; Warfarin or similar medicines &ndash; used to thin the blood. You may be more likely to have a bleed. Your doctor may need to take regular blood tests to check how well your blood can clot.</p><p>&bull; CYP3A4 or CYP3A5 inducers like rifampicin may impact effectiveness of the medicine.</p><p><strong>Pregnancy and breast-feeding </strong></p><p><u>Pregnancy </u></p><p>If you are pregnant or think you might be pregnant you should contact your doctor before<strong> </strong>taking LINDACIL.</p><p>Ask your doctor or pharmacist for advice before taking any medicine.</p><p><u>Breast-feeding </u></p><p>Tell your doctor if you will be breast-feeding while taking LINDACIL as Clindamycin may be passed into breast milk. Your doctor will decide if LINDACIL is appropriate for you. If you continue to take LINDACIL, you should stop breast-feeding.</p><p><strong>Driving and using machines </strong></p><p>No effects on the ability to drive or use machines have been seen with LINDACIL.</p><p><strong>LINDACIL Capsules contain lactose </strong></p><p>LINDACIL Capsules contains lactose a type of sugar. If you have been told that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p>LINDACIL Capsules should always be swallowed whole with a full glass of water.</p><p><strong>Adults and Elderly Patients </strong></p><p>The recommended dose of LINDACIL is between 150 and 450mg (1 to 3 capsules) every 6 hours, depending on the severity of your infection.</p><p><strong>Use in children </strong></p><p>This medicine is used for children who are able to swallow capsules. The recommended dose in children is between 12 and 25 mg / kg /day of bodyweight, divided into six hourly doses, depending on the severity of the infection. Your doctor will work out the number of capsules that your child should have. If your child is unable to swallow capsules, talk to your doctor or pharmacist.</p><p><strong>Long term use of LINDACIL </strong></p><p>If you have to take LINDACIL for a long time, your doctor may arrange regular liver, kidney and blood tests. Do not miss these check-ups with your doctor.</p><p>Long term use can also make you more likely to get other infections that do not respond to LINDACIL treatment.</p><p><strong>If you take more LINDACIL Capsules than you should </strong></p><p>If you accidentally take too many LINDACIL Capsules contact your doctor at once or go to the nearest hospital casualty department. Always take the labelled medicine package with you, whether there are any LINDACIL Capsules left or not. Do not take any more capsules until your doctor tells you to.</p><p><strong>If you forget to take LINDACIL </strong></p><p>If the forgotten dose is just a few hours late, use it straight away. If it is nearly time for your next dose miss out the forgotten one. Do not take a double dose to make up for a missed dose.<strong> </strong></p><p><strong>If you stop taking LINDACIL </strong></p><p>If you stop taking the medicine too soon your infection may come back again or get worse.</p><p>Do not stop taking LINDACIL unless your doctor tells you to.</p><p><strong>If you have any further questions on how to take this product, ask your doctor or pharmacist. </strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong>Tell your doctor immediately if you develop:</strong></p><p>&bull; Severe, persistent or bloody diarrhea (which may be associated with stomach pain or fever). This is an uncommon side effect which may occur during or after completing treatment with antibiotics and can be a sign of serious bowel inflammation or pseudomembranous colitis.</p><p>&bull; Signs of a severe allergic reaction such as sudden wheeziness, difficulty in breathing, dizziness, swelling of the eyelids, face, lips, throat or tongue, rash or itching (especially affecting the whole body).</p><p>&bull; Blistering and peeling of large areas of skin, fever, cough, feeling unwell and swelling of the gums, tongue or lips.</p><p>&bull; Yellowing of the skin and whites of the eyes (jaundice).</p><p><strong>&bull; Potentially life threatening skin rashes: </strong></p><p>- Widespread rash with blistering and peeling of large areas of skin, particularly around the mouth, nose, eyes or genitals, known as Stevens-Johnson syndrome, or a more severe form with extensive peeling of the skin (more than 30% of the body surface) known as <em>toxic epidermal necrolysis</em></p><p>- Rare skin eruption that is characterised by the rapid appearance of areas of red skin studded with small pustules (small blisters filled with white/yellow fluid) (Acute Generalised Exanthematous Pustulosis (AGEP)</p><p>- Skin rash, which may blister, and looks like central dark spots surrounded by a paler area, with a dark ring around the edge</p><p>- <em>erythema multiforme</em>&nbsp; &nbsp;</p><p>- Widespread red skin rash with small pus-containing blisters (<em>bullous exfoliative dermatitis</em>)</p><p>- Fever, swollen lymph nodes or skin rash, these may be symptoms of a condition known as DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) and can be severe and life-threatening.</p><p><strong>Other possible side effects may include: </strong></p><p><strong>Common (may affect up to 1 in 10 people):</strong></p><p>&middot; Abnormal liver function tests (poor liver function).</p><p>&middot; Pain in stomach / abdomen, diarrhea.</p><p><strong>Uncommon (may affect up to 1 in 100 people) </strong></p><p>&middot;&nbsp;Feeling sick or being sick.</p><p>&middot; Rash- characterized by a flat red area on the skin that is covered with small bumps and hives.</p><p><strong>Frequency cannot be estimated from the available data: </strong></p><p>&middot; Infection inside and around the vagina.</p><p>&middot;&nbsp;Inflammation of the large intestine which causes abdominal pain, fever or diarrhea due to infection by&nbsp;<em>Clostridioides difficile. </em></p><p>&middot;&nbsp;Effects on your blood system: reduced numbers of blood cells which may cause bruising or bleeding or weaken the immune system.</p><p>&middot;&nbsp;Changes in the way things taste.</p><p>&middot; Inflammation of the lining of the oesophagus (gullet), open sores or lesions in the lining of the oesophagus (gullet).</p><p>&middot;&nbsp;Yellowing of the skin and whites of the eyes (jaundice).</p><p>&middot; Red or scaly skin (exfoliative dermatitis), red measles-like rash (rash morbilliform), itching.</p><p><strong>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. </strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; Keep this medicine out of the sight and reach of children.</p><p>&bull; Do not use LINDACIL Capsules after the expiry date which is stated on the carton and blister labels. The expiry date refers to the last day of that month.</p><p>&bull; Do not store above 30&deg;C.</p><p>&bull; Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>The active substance is</strong> Clindamycin Hydrochloride.</p><p><strong>Each 150 mg</strong> capsule contains Clindamycin Hydrochloride equivalent to 150 mg of Clindamycin.</p><p><strong>Each 300 mg</strong> capsule contains Clindamycin Hydrochloride equivalent to 300 mg of Clindamycin.</p><p><strong>The other ingredients are</strong> spray dried lactose, maize starch, talc, magnesium stearate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                LINDACIL 150 mg Capsules are size (1) capsules, with white opaque body imprinted with 150 and white opaque cap imprinted with FP0034 filled with white to off-white powder.
LINDACIL 300 mg Capsules are size (0) capsule, with white opaque body imprinted with 300 and white opaque cap imprinted with FP0035 filled with white to off-white powder. 

LINDACIL 150 mg and 300 mg available in blister packs containing 8 capsules and each box contains two blisters (16 capsules) 


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Alrai Pharmaceutical Industries Co. (L.L.C.)</strong></p><p>Al Wadi - 2, Almu&rsquo;tasem Bellah Al Fatemy Street</p><p>P.O.Box: 9224 Jeddah - 21413 Kingdom of Saudi Arabia</p><p><u>Tel</u>: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; +966 12 2888949</p><p><u>Fax</u>: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; +966 12 2889014</p><p><u>E-mail:</u> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; info@alraipharma.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last approved in 07/2021, Revision 0.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">تحتوي كبسولات لينداسيل على المادة الفعالة كليندامايسين هيدروكلورايد التي تنتمي إلى مجموعة من المضادات الحيوية تسمى لينكوساميد المستخدمة في علاج الالتهابات البكتيرية الخطيرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تتناول لينداسيل</strong></p><p dir="RTL">إذا كنت تعاني من حساسية من الكليندامايسين أو لينكومايسين أو لأي من المكونات الأخرى في هذا الدواء (المذكورة في القسم 6).</p><p dir="RTL"><strong>التحذيرات والاحتياطات</strong></p><p dir="RTL"><strong>تحدث إلى طبيبك أو الصيدلي قبل استخدام لينداسيل إذا:</strong></p><p dir="RTL">&bull; لديك إسهال أو عادة ما تصاب بالإسهال عندما تتناول المضادات الحيوية أو تعاني من أي وقت مضى من مشاكل في المعدة أو الأمعاء. إذا أصبت بإسهال شديد أو مستمر أو دموي أثناء أو بعد استخدام لينداسيل، أخبر طبيبك على الفور لأنه قد يكون من الضروري مقاطعة العلاج. قد يكون هذا علامة على التهاب الأمعاء (التهاب القولون الغشائي الكاذب) الذي يمكن أن يحدث بعد العلاج بالمضادات الحيوية.</p><p dir="RTL">&bull; تعاني من مشاكل في كليتيك أو كبدك.</p><p dir="RTL">&bull; كنت تعاني من الربو والأكزيما أو حمى القش.</p><p dir="RTL">&bull; تصاب بأي تفاعلات جلدية شديدة أو فرط الحساسية للينداسيل.</p><p dir="RTL"><strong>لينداسيل والأدوية الأخرى</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تأخذ أو أخذت مؤخراً أي من الأدوية التي تحصل عليها دون وصفة طبية.</p><p dir="RTL">&bull; مرخيات العضلات المستخدمة للعمليات (مانع عصبي عضلي).</p><p dir="RTL">&bull; حبوب منع الحمل. يجب عليك استخدام وسائل منع حمل إضافية مثل الواقي الذكري أثناء تناول لينداسيل ولمدة سبعة أيام بعد تناول لينداسيل.</p><p dir="RTL">&bull; الوارفارين أو الأدوية المماثلة - تستخدم لسيولة الدم. قد تكون أكثر عرضة للنزيف. قد يحتاج طبيبك إلى إجراء اختبارات دم منتظمة للتحقق من مدى تجلط الدم.</p><p dir="RTL">&bull; قد تؤثر محفزات CYP3A4 أو CYP3A5 مثل ريفامبيسين على فعالية الدواء.</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL"><u>الحمل</u></p><p dir="RTL">إذا كنت حاملاً أو تعتقدين أنك حامل، فعليك الاتصال بطبيبك قبل تناول لينداسيل.</p><p dir="RTL">اسألي طبيبك أو الصيدلي للحصول على المشورة قبل تناول أي دواء.</p><p dir="RTL"><u>الرضاعة الطبيعية</u></p><p dir="RTL">أخبري طبيبك إذا كنت سترضعين طفلك رضاعة طبيعية أثناء تناول لينداسيل حيث قد ينتقل الكليندامايسين إلى حليب الأم سيقرر طبيبك ما إذا كانت كبسولات لينداسيل مناسبة لك أم لا. إذا كنتِ لا تزالي تأخذين لينداسيل، يجب عليك التوقف عن الرضاعة الطبيعية.</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">لم تلاحظ أي تأثيرات على القدرة على القيادة أو استخدام الآلات مع لينداسيل.</p><p dir="RTL"><strong>كبسولات لينداسيل تحتوي على اللاكتوز</strong></p><p dir="RTL">كبسولات لينداسيل تحتوي على نوع من السكر. إذا تم إخبارك بأنك لا تتحمل بعض السكريات، فأخبر طبيبك قبل تناول هذا المنتج.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تناول دائما لينداسيل تماماً حسب إرشادات طبيبك. راجع طبيبك أو الصيدلي إذا لم تكن متأكدًا.</p><p dir="RTL"><strong>يجب دائمًا ابتلاع كبسولات لينداسيل بالكامل مع كوب كامل من الماء.</strong></p><p dir="RTL"><strong>الكبار والمرضى المسنين</strong></p><p dir="RTL">تتراوح جرعة <strong>لينداسيل</strong> الموصى بها بين 150 و450 ملجم (1 إلى 3 كبسولات) كل 6 ساعات، وهذا يتوقف على شدة ونوع العدوى التي لديك.</p><p dir="RTL"><strong>استخدامها في الأطفال</strong></p><p dir="RTL">يستخدم هذا الدواء للأطفال القادرين على ابتلاع الكبسولات. تتراوح الجرعة الموصى بها عند الأطفال بين 12 و25 ملجم / كجم / من وزن الجسم، مقسمة إلى ست جرعات كل ساعة، وهذا يعتمد على شدة العدوى. سوف يحدد طبيبك عدد الكبسولات التي يجب أن يتناولها طفلك. إذا كان طفلك غير قادر على ابتلاع الكبسولات، فتحدث إلى طبيبك أو الصيدلي.</p><p dir="RTL"><strong>إذا استخدمت كبسولات لينداسيل لفترة طويلة </strong></p><p dir="RTL">إذا كنت مضطرًا إلى تناول <strong>لينداسيل</strong> لفترة طويلة، فقد يرتب لك طبيبك اختبارات الكبد والكلى والدم بانتظام. لا تفوت هذه الفحوصات مع طبيبك.</p><p dir="RTL">الاستخدام طويل الأمد يمكن أن يجعلك أكثر عرضة للإصابة بالتهابات أخرى لا تستجيب لعلاج <strong>لينداسيل</strong>.</p><p dir="RTL"><strong>إذا تناولت كبسولات لينداسيل بكمية أكبر مما يجب </strong></p><p dir="RTL">إذا أخذت عن طريق الخطأ جرعة زائدة من كبسولات <strong>لينداسيل</strong>، فاتصل بطبيبك على الفور أو اذهب إلى أقرب قسم طوارئ. احرص دائمًا على اصطحاب كرتون الدواء معك، سواء كانت هناك أي كبسولات <strong>لينداسيل</strong> أم لا. لا تتناول أي كبسولات أخرى حتى يخبرك طبيبك بذلك.</p><p dir="RTL"><strong>إذا نسيت أن تتناول لينداسيل</strong></p><p dir="RTL">إذا نسيت تناول جرعة من كبسولات <strong>لينداسيل</strong>، تناول الجرعة حالما تذكرت الا إذا كان موعد الجرعة الي تليها قد أوشك. في هذه الحالة، لا تتناول جرعة مضاعفة للتعويض عن الجرعة التي أغفلتها.</p><p dir="RTL"><strong>إذا توقفت عن تناول لينداسيل</strong></p><p dir="RTL">إذا توقفت عن تناول الدواء في وقت مبكر جدًا، فقد تعود العدوى مرة أخرى أو تزداد سوءًا.</p><p dir="RTL">لا تتوقف عن تناول <strong>لينداسيل </strong>ما لم يخبرك طبيبك بذلك.</p><p dir="RTL"><strong>إذا</strong><strong> </strong><strong>كانت</strong><strong> </strong><strong>لديك</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>أسئلة</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>استفسارات</strong><strong> </strong><strong>أخرى حول تناول هذا الدواء،</strong><strong> </strong><strong>استشر</strong><strong> </strong><strong>الطبيب</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>الصيدلي</strong><strong>.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو الحال مع جميع الأدوية يمكن أن يسبب <strong>لينداسيل</strong> أعراضاً جانبية. إلا أنها قد لا تحدث مع جميع المرضى. وتكون معظم هذه الأعراض خفيفة إلى متوسطة وتختفي بعد فترة قصيرة.</p><p dir="RTL"><strong>أخبر طبيبك على الفور إذا حصل لك:</strong></p><p dir="RTL">&bull; إسهال شديد أو مستمر أو دموي (قد يرتبط بألم في المعدة أو حمى). هذا أحد الآثار الجانبية غير الشائعة التي قد تحدث أثناء أو بعد الانتهاء من العلاج بالمضادات الحيوية ويمكن أن تكون علامة على التهاب الأمعاء الخطير أو التهاب القولون الغشائي الكاذب.</p><p dir="RTL">&bull; علامات رد الفعل التحسسي الحاد مثل الصرع المفاجئ، صعوبة في التنفس، الدوخة، تورم الجفون، الوجه، الشفاه، الحلق أو اللسان، الطفح الجلدي أو الحكة (خاصة التي تؤثر على الجسم كله).</p><p dir="RTL">&bull; تقرحات وتقشير مساحات كبيرة من الجلد والحمى، السعال، الشعور بالإعياء وتورم اللثة، اللسان أو الشفاه.</p><p dir="RTL">&bull; اصفرار الجلد وبياض العينين (اليرقان).</p><p dir="RTL"><strong>طفح جلدي حاد قد يشكل خطر على الحياة:</strong></p><p dir="RTL">&bull;طفح جلدي واسع الانتشار مع ظهور تقرحات في مساحات كبيرة من الجلد، خاصة حول الفم، الأنف، العينين أو الأعضاء التناسلية، المعروفة باسم متلازمة ستيفنز - جونسون، أو شكل أكثر حدة مع تقشير في الجلد على نطاق واسع (أكثر من 30 ٪ من سطح الجسم) المعروف باسم تحلل البشرة السامة،</p><p dir="RTL">&bull; تهيج نادر في الجلد يتميز بسرعة ظهور بقع حمراء في الجلد مع بثور صغيرة (بثور صغيرة مملوءة بالسائل الأبيض أو الأصفر) (البُثار الطفحي المعمم الحاد (AGEP))</p><p dir="RTL">&bull; طفح جلدي، قد يحتوي على فقاعات، يبدو كأنه بقع داكنة مركزية محاطة بمنطقة شاحبة، مع حلقة داكنة حول الحافة - حمامي متعددة الأشكال)</p><p dir="RTL">&bull; طفح جلدي أحمر واسع الانتشار مع ظهور بثور صغيرة تحتوي على القيح (التهاب الجلد التقشري الفقاعي)</p><p dir="RTL">&bull; حمى، وتضخم الغدد الليمفاوية أو طفح جلدي، وهذه قد تكون أعراضًا لحالة تعرف باسم DRESS (التفاعلات الدوائية مع فرط الحمضات والأعراض الجهازية) وقد تكون شديدة وتهدد الحياة.</p><p dir="RTL"><strong>وقد تشمل الآثار الجانبية الأخرى المحتملة:</strong></p><p dir="RTL"><strong>شائع (قد يؤثر على شخص واحد من كل 10 أشخاص):</strong></p><p dir="RTL">&bull; اختبارات وظائف الكبد غير الطبيعية (ضعف في وظائف الكبد).</p><p dir="RTL">&bull; ألم في المعدة / البطن، الإسهال.</p><p dir="RTL"><strong>غير شائع (قد يؤثر على ما يصل إلى شخص من كل 100 شخص)</strong></p><p dir="RTL">&bull; الشعور بالمرض أو المرض.</p><p dir="RTL">&bull; طفح جلدي يتميز بمنطقة حمراء على الجلد منتفخة.</p><p dir="RTL"><strong>لا يمكن تقدير التكرار من البيانات المتاحة:</strong></p><p dir="RTL">&bull; عدوى داخل وحول المهبل.</p><p dir="RTL">&bull; التهاب الأمعاء الغليظة الذي يسبب آلام في البطن أو الحمى أو الإسهال بسبب عدوى المطثية العسيرة.</p><p dir="RTL">&bull; التغيرات التي تحصل في الدم: انخفاض عدد خلايا الدم التي قد تسبب كدمات أو نزيف أو إضعاف الجهاز المناعي.</p><p dir="RTL">&bull; التغيير في طريقة تذوق الأشياء.</p><p dir="RTL">&bull; التهاب بطانة المريء، القروح المفتوحة في بطانة المريء.</p><p dir="RTL">&bull; اصفرار الجلد وبياض العينين (اليرقان).</p><p dir="RTL">&bull; جلد أحمر أو متقشر (التهاب الجلد التقشري)، طفح جلدي يشبه الحصبة، حكة.</p><p dir="RTL"><strong>في حال زادت الأعراض الجانبية سوءً، أو لاحظت أعراض جانبية غير مذكورة في هذه النشرة، قم بالتواصل مع الطبيب أو الصيدلي.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&bull; قم بتخزين هذا الدواء بعيدا عن متناول الأطفال.</p><p dir="RTL">&bull; لا تستخدم كبسولات <strong>لينداسيل</strong> بعد تاريخ انتهاء الصلاحية الموضح على الكرتون والقصدير. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">&bull; لا يُخزن في درجة حرارة أكثر من 30 درجة مئوية.</p><p dir="RTL">&bull; يجب عدم التخلص من الأدوية في مياه الصرف أو مع مخلفات المنزل. أسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجتها. لأن هذه الإجراءات ستساعد على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>المادة الفعالة هي</strong> كليندامايسين هيدروكلورايد.</p><p>كل <u>كبسولة 150 ملجم</u> تحتوي على كليندامايسين هيدروكلورايد أي ما يعادل 150 ملجم من الكليندامايسين.</p><p>كل <u>كبسولة 300 ملجم</u> تحتوي على كليندامايسين هيدروكلورايد أي ما يعادل 300 ملجم من الكليندامايسين.</p><p><strong>المكونات الأخرى هي</strong> رش اللاكتوز المجفف، نشا الذرة، التلك، ستيرات المغنيسيوم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p><u>كبسولات <strong>لينداسيل</strong> 150 ملجم</u> عبارة عن كبسولات حجمها (1)، الجزء السفلي لونه أبيض ومحفور عليه رقم (150)، والجزء العلوي لونه أبيض محفور عليه FP0034)) ومملوءة ببودرة بيضاء مائلة للون السكري.&nbsp;</p><p><u>كبسولات <strong>لينداسيل</strong> </u><u>300</u><u> ملجم</u> عبارة عن كبسولات حجمها (0)، الجزء السفلي لونه أبيض ومحفور عليه رقم (300)، والجزء العلوي لونه أبيض محفور عليه FP0035)) ومملوءة ببودرة بيضاء مائلة للون السكري.&nbsp;</p><p>&nbsp;</p><p dir="RTL"><strong>لينداسيل 150 ملجم و300 ملجم</strong> متوفر في شريط يحتوي على 8 كبسولات وكل كرتون يحتوي على شريطين (16 كبسولة)</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>شركة</strong><strong> </strong><strong>مصنع</strong><strong> </strong><strong>الرأي</strong><strong> </strong><strong>للصناعات</strong><strong> </strong><strong>الدوائية </strong><strong>&nbsp;(</strong><strong>ذ</strong><strong>.</strong><strong>م</strong><strong>.</strong><strong>م</strong><strong>.)</strong></p><p dir="RTL">الوادي- 2، شارع المعتصم بالله الفاطمي</p><p dir="RTL">صندوق بريد: 9224 جدة - ٢١٤١٣ المملكة العربية السعودية</p><p dir="RTL">تلفون:&nbsp;&nbsp;&nbsp; &nbsp;2888949 12 966 +&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p><p dir="RTL">فاكس:&nbsp; &nbsp;2889014 12 966 +&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</p><p dir="RTL">ايميل:&nbsp; Info@alraipharma.com&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تم اعتماد هذه النشرة في 07/2021  نسخة رقم 0 
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Lindacil 150 mg Capsules
Lindacil 300 mg Capsules
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each 150 mg capsule contains the active ingredient Clindamycin Hydrochloride equivalent to 150 mg Clindamycin.

Each 300 mg capsule contains the active ingredient Clindamycin Hydrochloride equivalent to 300 mg Clindamycin.

For the full list of excipients, see section 6.1

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Capsule

Lindacil 150 mg Capsules are size (1) capsules, with white opaque body imprinted with 150 and white opaque cap imprinted with FP0034 filled with white to off-white powder.

Lindacil 300 mg Capsules are size (0) capsule, with white opaque body imprinted with 300 and white opaque cap imprinted with FP0035 filled with white to off-white powder.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Antibacterial. Serious infections caused by susceptible Gram-positive organisms, staphylococci (both penicillinase- and non-penicillinase-producing), streptococci (except&nbsp;<em>Streptococcus faecalis</em>) and pneumococci. It is also indicated in serious infections caused by susceptible anaerobic pathogens.</p><p>Clindamycin does not penetrate the blood/brain barrier in therapeutically effective quantities.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u></p><p><em>Adults:</em>&nbsp;Moderately severe infection, 150 - 300 mg every six hours; severe infection, 300 - 450 mg every six hours.</p><p><em>Elderly patients:</em>&nbsp;The half-life, volume of distribution and clearance, and extent of absorption after administration of Clindamycin hydrochloride are not altered by increased age. Analysis of data from clinical studies has not revealed any age-related increase in toxicity. Dosage requirements in elderly patients, therefore, should not be influenced by age alone.</p><p><em>Paediatric population</em></p><p>Clindamycin hydrochloride capsules should only be used for children who are able to swallow capsules</p><p>Doses of 12-25 mg/kg/day six hourly depending on the severity of the infection.</p><p>The use of whole capsules may not be suitable to provide the exact mg/kg doses required for the treatment of children.</p><p><em>Dosage in Renal /Hepatic Impairment:&nbsp;</em>Clindamycin dosage modification is not necessary in patients with renal or hepatic insufficiency.</p><p>Note: In cases of beta-haemolytic streptococcal infection, treatment with Lindacil should continue for at least 10 days to diminish the likelihood of subsequent rheumatic fever or glomerulonephritis.</p><p><u>Method of administration</u></p><p>Oral. Lindacil Capsules should always be taken with a full glass of water. Absorption of Lindacil is not appreciably modified by the presence of food.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Lindacil is contra-indicated in patients previously found to be sensitive to Clindamycin, lincomycin or to any of the excipients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Warnings:</em></p><p>Severe hypersensitivity reactions, including severe skin reactions such as drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and acute generalised exanthematous pustulosis (AGEP) have been reported in patients receiving Clindamycin therapy. If a hypersensitivity or severe skin reaction occurs, Clindamycin should be discontinued and appropriate therapy should be initiated (see sections 4.3 and 4.8).</p><p>Lindacil should only be used in the treatment of serious infections. In considering the use of the product, the practitioner should bear in mind the type of infection and the potential hazard of the diarrhoea which may develop, since cases of colitis have been reported during, or even two or three weeks following, the administration of Clindamycin.</p><p>Studies indicate a toxin(s) produced by clostridia (especially&nbsp;<em>Clostridioides difficile</em>) is the principal direct cause of antibiotic-associated colitis. These studies also indicate that this toxigenic clostridium is usually sensitive&nbsp;<em>in vitro</em>&nbsp;to vancomycin. When 125 mg to 500 mg of vancomycin are administered orally four times a day for 7 - 10 days, there is a rapid observed disappearance of the toxin from faecal samples and a coincident clinical recovery from the diarrhoea. (Where the patient is receiving cholestyramine in addition to vancomycin, consideration should be given to separating the times of administration).</p><p>Colitis is a disease which has a clinical spectrum from mild, watery diarrhoea to severe, persistent diarrhoea, leucocytosis, fever, severe abdominal cramps, which may be associated with the passage of blood and mucus. If allowed to progress, it may produce peritonitis, shock and toxic megacolon. This may be fatal.</p><p>The appearance of marked diarrhoea should be regarded as an indication that the product should be discontinued immediately. The disease is likely to follow a more severe course in older patients or patients who are debilitated. Diagnosis is usually made by the recognition of the clinical symptoms, but can be substantiated by endoscopic demonstration of pseudomembranous colitis. The presence of the disease may be further confirmed by culture of the stool for&nbsp;<em>Clostridioides difficile</em>&nbsp;on selective media and assay of the stool specimen for the toxin(s) of&nbsp;<em>C. difficile.</em></p><p><em>Clostridioides difficile&nbsp;</em>associated diarrhoea (CDAD) has been reported with use of nearly all antibacterial agents, including Clindamycin, and may range in severity from mild diarrhoea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of&nbsp;<em>C difficile.</em></p><p><em>C. difficile&nbsp;</em>produces toxins A and B which contribute to the development of CDAD.</p><p>Hypertoxin producing strains of&nbsp;<em>C. difficile&nbsp;</em>cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must be considered in all patients who present with diarrhoea following antibiotic use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents.</p><p><em>Precautions:</em>&nbsp;Caution should be used when prescribing Lindacil to individuals with a history of gastro-intestinal disease, especially colitis.</p><p>Periodic liver and kidney function tests should be carried out during prolonged therapy. Such monitoring is also recommended in neonates and infants.</p><p>Prolonged administration of Lindacil, as with any anti-infective, may result in super-infection due to organisms resistant to Clindamycin.</p><p>Care should be observed in the use of Lindacil in atopic individuals.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Clindamycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents. Therefore it should be used with caution in patients receiving such agents.</p><p>Vitamin K antagonists</p><p>Increased coagulation tests (PT/INR) and/or bleeding, have been reported in patients treated with Clindamycin in combination with a vitamin K antagonist (e.g. warfarin, acenocoumarol and fluindione). Coagulation tests, therefore, should be frequently monitored in patients treated with vitamin K antagonists.</p><p>Co-administration of Clindamycin with inhibitors of CYP3A4 and CYP3A5</p><p>Clindamycin is metabolized predominantly by CYP3A4, and to a lesser extent by CYP3A5, to the major metabolite Clindamycin sulfoxide and minor metabolite N-desmethylClindamycin. Therefore inhibitors of CYP3A4 and CYP3A5 may reduce Clindamycin clearance and inducers of these isoenzymes may increase Clindamycin clearance. In the presence of strong CYP3A4 inducers such as rifampicin, monitor for loss of effectiveness.</p><p>In vitro studies indicate that Clindamycin does not inhibit CYP1A2, CYP2C9, CYP2C19, CYP2E1 or CYP2D6 and only moderately inhibits CYP3A4. Therefore, clinically important interactions between Clindamycin and co-administered drugs metabolized by these CYP enzymes are unlikely.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>There was evidence of maternal toxicity and embryofoetal toxicity in animal studies (see section 5.3).</p><p>Clindamycin crosses the placenta in humans. After multiple doses, amniotic fluid concentrations were approximately 30% of maternal blood concentrations.</p><p>In clinical trials with pregnant women, the systemic administration of Clindamycin during the second and third trimesters has not been associated with an increased frequency of congenital abnormalities. There are no adequate and well-controlled studies in pregnant women during the first trimester of pregnancy. Clindamycin should be used in pregnancy only if clearly needed.</p><p><u>Breast-feeding</u></p><p>Orally and parenterally administered Clindamycin has been reported to appear in human breast milk in ranges from 0.7 to 3.8&micro;g/mL. Because of the potential for serious adverse reactions in nursing infants, Clindamycin should not be taken by nursing mothers.</p><p><u>Fertility</u></p><p>Fertility studies in rats treated orally with Clindamycin revealed no effects on fertility or mating ability.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Clindamycin has no or negligible influence on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The table below lists the adverse reactions identified through clinical trial experience and post-marketing surveillance by system organ class and frequency. Adverse reactions identified from post-marketing experience are included in italics. The frequency grouping is defined using the following convention: Very common (&ge;1/10); Common (&ge; 1/100 to &lt;1/10); Uncommon (&ge;1/1,000 to &lt;1/100); Rare (&ge; 1/10,000 to &lt;1/1,000); Very Rare (&lt; 1/10,000); and Not known (cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.</p><table border="1" cellspacing="0" cellpadding="0" style="width:682px"><tbody><tr><td><p><strong>System Organ Class</strong></p></td><td><p><strong>Common</strong></p><p><strong>&ge;1/100 to &lt;1/10</strong></p></td><td><p><strong>Uncommon</strong></p><p><strong>&ge;1/1 000 to &lt;1/100</strong></p></td><td style="width:99px"><p><strong>Rare</strong></p><p><strong>&ge;1/10 000 to &lt;1/1 000</strong></p></td><td style="width:216px"><p><strong>Not Known (cannot be estimated from available data)</strong></p></td></tr><tr><td><p>Infections and infestations</p></td><td style="vertical-align:top"><p>Pseudomembranous colitis*#</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top; width:99px">&nbsp;</td><td style="vertical-align:top; width:216px"><p><em>Clostridioides difficile</em>&nbsp;colitis*</p><p>Vaginal infection*</p></td></tr><tr><td><p>Blood and Lymphatic System Disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top; width:99px">&nbsp;</td><td style="vertical-align:top; width:216px"><p>Agranulocytosis* Neutropenia* Thrombocytopenia* Leukopenia* Eosinophilia</p></td></tr><tr><td><p>Immune System Disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top; width:99px">&nbsp;</td><td style="vertical-align:top; width:216px"><p>Anaphylactic shock* Anaphylactoid reaction*</p><p>Anaphylactic reaction*</p><p>Hypersensitivity*</p></td></tr><tr><td><p>Nervous System Disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top; width:99px">&nbsp;</td><td style="vertical-align:top; width:216px"><p>Dysgeusia</p></td></tr><tr><td><p>Gastrointestinal Disorders</p></td><td style="vertical-align:top"><p>Diarrhea, Abdominal pain</p></td><td style="vertical-align:top"><p>Vomiting Nausea</p></td><td style="vertical-align:top; width:99px">&nbsp;</td><td style="vertical-align:top; width:216px"><p>Oesophageal ulcer*&Dagger; Oesophagitis*&Dagger;</p></td></tr><tr><td><p>Hepatobiliary Disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top; width:99px">&nbsp;</td><td style="vertical-align:top; width:216px"><p>Jaundice*</p></td></tr><tr><td><p>Skin and Subcutaneous Tissue Disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Rash maculo-papular, Urticaria</p></td><td style="vertical-align:top; width:99px">&nbsp;</td><td style="vertical-align:top; width:216px"><p>Toxic epidermal necrolysis (TEN)*</p><p>Stevens-Johnson syndrome (SJS)*</p><p>Drug reaction with eosinophilia and systemic symptoms (DRESS)*</p><p>Acute generalised exanthematous pustulosis (AGEP)*, angioedema*, dermatitis exfoliative* Dermatitis bullous*</p><p>Erythema multiforme, pruritus, rash morbilliform*</p></td></tr><tr><td><p><strong>Investigations</strong></p></td><td style="vertical-align:top"><p>Abnormal liver function test</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top; width:99px">&nbsp;</td><td style="vertical-align:top; width:216px">&nbsp;</td></tr></tbody></table><p>* ADR identified post-marketing.</p><p>&Dagger; ADRs apply only to oral formulations.</p><p># See section 4.4.</p><p><strong>Reporting of suspected adverse reactions</strong></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.</p><p><strong>To report any side effect(s):</strong></p><p><strong>Saudi Arabia:</strong></p><p>The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>&middot;&nbsp;Fax: +966-11-205-7662</p><p>&middot;&nbsp;Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>&middot; Toll free phone: 8002490000</p><p>&middot; E-mail: npc.drug@sfda.gov.sa</p><p>&middot;&nbsp;Website: www.sfda.gov.sa/npc</p><p><strong>Other GCC States:</strong></p><p>Please contact the relevant competent authority.<strong> </strong></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In cases of overdosage, no specific treatment is indicated.</p><p>The serum biological half-life of Clindamycin is 2.4 hours. Hemodialysis and peritoneal dialysis are not effective in removing Clindamycin from the serum.</p><p>If an allergic adverse reaction occurs, therapy should be with the usual emergency treatments, including corticosteroids, adrenaline and antihistamines.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Lincocosamide antibiotics, ATC Code D10AF01.</p><p><u>Mode of action</u></p><p>Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as Clindamycin bind to the 50S subunit of the bacterial ribosome similarly to macrolides such as erythromycin and inhibit protein synthesis. The action of Clindamycin is predominantly bacteriostatic although high concentrations may be slowly bactericidal against sensitive strains. Although Clindamycin phosphate is inactive&nbsp;<em>in vitro</em>, rapid&nbsp;<em>in vivo</em>&nbsp;hydrolysis converts this compound to the antibacterially active Clindamycin.</p><p><u>Resistance</u></p><p>Resistance to Clindamycin usually occurs via macrolide-lincosamide-streptogramin B (MLSB) type of resistance, which may be constitutive or inducible.</p><p><u>Breakpoints</u></p><p>The minimum inhibitory concentrations (MIC) breakpoints are as follows:</p><p>EUCAST</p><p><em>Staphylococci</em>: sensitive &le; 0.25 resistant &gt; 0.5</p><p><em>Streptococci ABCG</em>&nbsp;and&nbsp;<em>pneumoniae</em>: sensitive &le; 0.5 resistant &gt; 0.5</p><p>Gram positive anaerobes: sensitive &le; 4 resistant &gt; 4</p><p>Gram negative anaerobes: &le; 4 resistant &gt; 4</p><p><u>PK/PD relationship</u></p><p>Efficacy is related to the ratio of the area of the concentration-time curve of unbound antibiotic to the MIC for the pathogen (fAUC/MIC).</p><p><u>Susceptibility</u></p><p>The prevalence of acquired resistance may vary geographically and with time for selected species and local information on resistance is desirable, particularly when treating severe infections. As necessary, expert advice should be sought when local prevalence of resistance is such that the utility of the agent in at least some types of infections is questionable.</p><p><strong>Species</strong></p><p><strong>Susceptible</strong></p><p><strong>Gram-positive aerobes</strong></p><p><em>Staphylococcus aureus*</em></p><p><em>Staphylococcus epidermidis</em></p><p><em>Streptococcus pneumonia</em></p><p><em>Streptococcus pyogenes</em></p><p><em>Viridans streptococci</em></p><p><strong>Anaerobes</strong></p><p><em>Bacteriodes fragilis</em>&nbsp;group</p><p><em>Prevotella formerly known as Bacteroides melaninogenicus</em></p><p><em>Bifidobacterium&nbsp;</em>spp.</p><p><em>Clostridium perfringens</em></p><p><em>Eubacterium&nbsp;</em>spp.</p><p><em>Fusobacterium&nbsp;</em>spp.</p><p><em>Peptococcus&nbsp;</em>spp.</p><p><em>Peptostreptococcus&nbsp;</em>spp.</p><p><em>Propionibacterium&nbsp;</em>spp.</p><p><em>Veillonella&nbsp;</em>spp.</p><p><strong>Resistant</strong></p><p><em>Clostridia&nbsp;</em>spp.</p><p><em>Enterococci</em></p><p><em>Enterobacteriaceae</em></p><p>*Up to 50% of methicillin-susceptible&nbsp;<em>S. aureus</em>&nbsp;have been reported to be resistant to Clindamycin in some areas. More than 90% of methicillin-resistant&nbsp;<em>S.aureus</em>&nbsp;(MRSA) are resistant to Clindamycin and it should not be used while awaiting susceptibility test results if there is any suspicion of MRSA.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>General characteristics of active substance</u></p><p>About 90% of a dose of Clindamycin hydrochloride is absorbed from the gastro-intestinal tract; concentrations of 2 to 3 micrograms per ml occur within one hour after a 150 mg dose of Clindamycin, with average concentrations of about 0.7 micrograms per ml after 6 hours. After doses of 300 and 600 mg peak plasma concentrations of 4 and 8 micrograms per ml, respectively, have been reported. Absorption is not significantly diminished by food in the stomach but the rate of absorption may be reduced.</p><p>Clindamycin is widely distributed in body fluids and tissues including bone, but it does not reach the csf in significant concentrations. It diffuses across the placenta into the foetal circulation and has been reported to appear in breast milk. High concentrations occur in bile. It accumulates in leucocytes and macrophages. Over 90% of Clindamycin in the circulation is bound to plasma proteins. In vitro studies in human liver and intestinal microsomes indicated that Clindamycin is predominantly oxidized by CYP3A4, with minor contribution from CYP3A5, to form Clindamycin sulfoxide and a minor metabolite, N-desmethylClindamycin. The half-life is 2 to 3 hours, although this may be prolonged in pre-term neonates and patients with severe renal impairment.</p><p>Clindamycin undergoes metabolism, presumably in the liver, to the active&nbsp;<em>N</em>-demethyl and sulphoxide metabolites, and also some inactive metabolites. About 10% of a dose is excreted in the urine as active drug or metabolites and about 4% in the faeces; the remainder is excreted as inactive metabolites. Excretion is slow, and takes place over several days. It is not effectively removed from the blood by dialysis.</p><p><u>Characteristics in patients</u></p><p>No special characteristics. See section 4.4 &quot;Special warnings and special precautions for use&quot; for further information.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None stated</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Spray Dried Lactose</p><p>Maize Starch</p><p>Talc</p><p>Magnesium Stearate</p><p>Hard gelatin capsules size zero</p><p>Hard gelatin capsules size one</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Lindacil 150 mg and 300 mg Capsule is</strong> supplied in transparent PVC/PVDC - Aluminum foil blisters.</p><p>Each Blister contains 8 Capsules and each box contains two blisters (16 capsules)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Alrai Pharmaceutical Industries Co. (L.L.C.) 
Al Wadi - 2, Almu'tasem Bellah Al Fatemy Street 
P.O.Box: 9224 
Postal code: 21413 Jeddah - 22518 
Kingdom of Saudi Arabia 
Tel: +966 12 2888949 
Fax: +966 12 2889014 
E-mail: info@alraipharma.com

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                07/2021
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>